Head-To-Head Analysis: Hims & Hers Health (NYSE:HIMS) versus Clover Health Investments (NASDAQ:CLOV)

Hims & Hers Health (NYSE:HIMS) and Clover Health Investments (NASDAQ:CLOV) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, earnings, valuation, profitability, dividends and institutional ownership.

Profitability

This table compares Hims & Hers Health and Clover Health Investments’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	6.05%	24.67%	9.37%
Clover Health Investments	-3.29%	-16.79%	-9.95%

Analyst Recommendations

This is a breakdown of recent recommendations for Hims & Hers Health and Clover Health Investments, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	3	10	2	0	1.93
Clover Health Investments	1	2	2	1	2.50

Hims & Hers Health currently has a consensus price target of $45.27, suggesting a potential upside of 35.85%. Clover Health Investments has a consensus price target of $3.93, suggesting a potential upside of 75.62%. Given Clover Health Investments’ stronger consensus rating and higher possible upside, analysts clearly believe Clover Health Investments is more favorable than Hims & Hers Health.

Volatility and Risk

Hims & Hers Health has a beta of 2.2, indicating that its share price is 120% more volatile than the S&P 500. Comparatively, Clover Health Investments has a beta of 2.07, indicating that its share price is 107% more volatile than the S&P 500.

Earnings & Valuation

This table compares Hims & Hers Health and Clover Health Investments”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$1.48 billion	5.14	$126.04 million	$0.54	61.71
Clover Health Investments	$1.37 billion	0.84	-$43.01 million	($0.11)	-20.32

Hims & Hers Health has higher revenue and earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

63.5% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are owned by institutional investors. 13.7% of Hims & Hers Health shares are owned by insiders. Comparatively, 24.1% of Clover Health Investments shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Hims & Hers Health beats Clover Health Investments on 10 of the 14 factors compared between the two stocks.

About Hims & Hers Health

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

About Clover Health Investments

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.